McAdam, LLC

Position in CGTX — Cognition Therapeutics Inc

CIK 1695490 Philadelphia, PA

Position in CGTX

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$74,235

+$21,071 QoQ

Shares Held

64,553

-7.7% QoQ

Ownership

0.068%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#24

of 66 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

McAdam, LLC holds $891,103 across 5 Biotechnology names. CGTX ranks #4 (8.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DFTX	Definium Therapeutics, Inc.	6,879	$323,588
2	VRTX	Vertex Pharmaceuticals Inc / Ma	543	$269,724
3	IBRX	ImmunityBio, Inc.	21,409	$187,435
4	CGTX	Cognition Therapeutics Inc This page	64,553	$74,235
5	CMPX	Compass Therapeutics, Inc.	16,494	$36,121

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$74,235	64,553	-7.7%	Shares	Sole	2026-08-04
2026-03-31	$53,164	69,953	-5.6%	Shares	Sole	2026-05-08
2025-12-31	$100,047	74,109	+2.8%	Shares	Sole	2026-02-13
2025-09-30	$97,301	72,075	—	Shares	Sole	2025-10-29
No filing history on record for this holder in this stock.